Advertisement
News
Advertisement

EndyMed Announces the World's First 3DEEP RF Skin Tightening and Fractional Skin Resurfacing Combined Treatment Platform

Mon, 05/23/2011 - 12:35pm
Bio-Medicine.Org

CAESAREA, Israel, May 23, 2011 /PRNewswire/ -- EndyMed Medical, Ltd., www.endymed.com, a leader in the use of multi-source radiofrequency for professional aesthetic treatments, announced today that the results of a new study will be presented at the upcoming 22nd World Congress of Dermatology, in Seoul, Korea.  The study, which focused on combination therapy and was done with the EndyMed PRO system using proprietary 3DEEP RF technology, was conducted by Li-Lin Liu, M.D., of the Department of Dermatology in Taiwan.

(Photo: http://photos.prnewswire.com/prnh/20110523/NE07097 )

The EndyMed PRO treatment system is the world's first device that offers, on the same platform, both 3DEEP multi-source, phase controlled RF for face and body tightening plus the FDA cleared multisource fractional RF skin resurfacing.

The study centered on anti-aging treatment for dorsal hands and neck, body areas which are challenging to treat, which were treated using a combination of non-ablative 3DEEP RF technology and fractional 3DEEP RF technology to achieve effective and safe results.

Major conclusions of the study are:

For dorsal hands, 86% of the patients had improvement following six treatments and with one month follow-up. The multi-source, phase controlled RF device was likely to improve the skin laxity and wrinkles on the dorsal hands and fingers.   For the neck area, 71% of the patients had improvement following two treatments. To treat deeper lines in the neck, it is expected that five to six sessions of the combination non-ablative and fractional 3DEEP RF treatments will prove effective on the bothersome and difficult to treat anti-aging complaint of deep neck lines. Since collagen takes three to six months to regenerate, a six month follow-up will be amended to the study. Patient

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading